• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume10, Issue4

BIOPSY IS NOT THE END, EFFICACY OF IHC AIDED DIAGNOSIS IN DETERMINING THE MODALITY OF TREATMENT IN LIPOSARCOMA

    Dr.N.Nivedha, Dr.R.Muthukumar M.S

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 4, Pages 440-444

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Liposarcoma are malignant tumour of fatty tissue and are the malignant counterpart to benign lipoma. They are the second most common type of soft tissue sarcoma. There are 3 groups of liposarcoma well-differentiated (WDL) and dedifferentiated liposarcoma (DDL), myxoid/round cell liposarcoma, and pleomorphic liposarcoma. In all 3 groups, complete surgical resection is central in treatment aimed at cure and is based on grade. Radiation can reduce risk of local recurrence in high-grade lesions like dedifferentiated liposarcoma or minimize surgical morbidity in the myxoid/round cell liposarcoma group. Classification based on histological appearance is not always precise, especially because of the partial overlap of histological features of well-differentiated liposarcoma and Pleomorphic liposarcoma that may be better differentiated based on MDM2 expression on Immunohistochemistry. Detection of MDM2 and CDK4 amplification serves to determine the treatment modality. The differential diagnosis between well-differentiated liposarcoma and dedifferentiated liposarcoma from their morphologic counterparts is challenging
Keywords:
    Soft tissue tumour liposarcomas histopathology immunohistochemistry
  • PDF (240 K)
  • XML
(2023). BIOPSY IS NOT THE END, EFFICACY OF IHC AIDED DIAGNOSIS IN DETERMINING THE MODALITY OF TREATMENT IN LIPOSARCOMA. European Journal of Molecular & Clinical Medicine, 10(4), 440-444.
Dr.N.Nivedha, Dr.R.Muthukumar M.S. "BIOPSY IS NOT THE END, EFFICACY OF IHC AIDED DIAGNOSIS IN DETERMINING THE MODALITY OF TREATMENT IN LIPOSARCOMA". European Journal of Molecular & Clinical Medicine, 10, 4, 2023, 440-444.
(2023). 'BIOPSY IS NOT THE END, EFFICACY OF IHC AIDED DIAGNOSIS IN DETERMINING THE MODALITY OF TREATMENT IN LIPOSARCOMA', European Journal of Molecular & Clinical Medicine, 10(4), pp. 440-444.
BIOPSY IS NOT THE END, EFFICACY OF IHC AIDED DIAGNOSIS IN DETERMINING THE MODALITY OF TREATMENT IN LIPOSARCOMA. European Journal of Molecular & Clinical Medicine, 2023; 10(4): 440-444.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 20
  • PDF Download: 41
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus